$HLN

Haleon plc

$8.87
-0.22 (-2.42%) Today

About Haleon plc

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

CEO
Mr. Brian James McNamara
Employees
24,535
Headquarters
Weybridge, United Kingdom
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Website
haleon.com

Key stats

Market Cap
$39.16B
P/E Ratio
17.74
Avg Volume (3M)
8.79M
EPS
$0.50
Day's Range
$8.82 – $9.07

Fundamentals as of Jun 18, 2026